RNase Z1 inhibitors represent a class of chemical compounds designed to inhibit the activity of RNase Z1, an enzyme responsible for the endonucleolytic cleavage of transfer RNA (tRNA) precursors at their 3' termini. RNase Z1, also known as tRNase Z, belongs to the family of metallo-β-lactamase-related proteins and plays a crucial role in the maturation and processing of tRNA, ensuring the proper removal of extra nucleotides to generate mature tRNA molecules with functional CCA-ends. By regulating this enzyme, RNase Z1 inhibitors can modulate the precise steps of RNA metabolism, which are fundamental to RNA stability and function. The inhibition mechanism typically involves interference with the enzyme's active site or coordination of the catalytic metal ions required for its activity, often involving zinc ions at the catalytic core of the enzyme.
These inhibitors are valuable for studying the enzymatic pathways involved in RNA processing, offering insights into the structural and functional aspects of RNase Z1 and related enzymes. The ability to selectively inhibit RNase Z1 has facilitated the elucidation of various biochemical processes dependent on tRNA maturation, providing a deeper understanding of RNA processing networks in both prokaryotic and eukaryotic systems. Additionally, investigating RNase Z1 inhibitors offers significant information on the structural dynamics of metalloenzymes and contributes to the broader study of ribonuclease activity across different biological contexts. These chemical tools are essential for further dissecting the role of RNase Z1 in cellular homeostasis, RNA metabolism, and enzyme kinetics, paving the way for the development of new biochemical assays and experimental models centered on RNA biology.
SEE ALSO...
Items 1 to 10 of 21 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Mithramycin A | 18378-89-7 | sc-200909 | 1 mg | $54.00 | 6 | |
As an inhibitor of DNA-binding transcription factors, Mithramycin A can indirectly influence gene expression, potentially impacting ELAC1. | ||||||
Ribavirin | 36791-04-5 | sc-203238 sc-203238A sc-203238B | 10 mg 100 mg 5 g | $62.00 $108.00 $210.00 | 1 | |
A nucleoside analog that can interfere with RNA metabolism, potentially impacting RNA processing. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $73.00 $238.00 $717.00 $2522.00 $21420.00 | 53 | |
Binds to DNA and inhibits RNA synthesis, potentially affecting RNA processing and maturation. | ||||||
Fluorouracil | 51-21-8 | sc-29060 sc-29060A | 1 g 5 g | $36.00 $149.00 | 11 | |
A pyrimidine analog that disrupts RNA synthesis and function, possibly affecting RNA maturation. | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $92.00 $209.00 | 33 | |
As an inhibitor of dihydrofolate reductase, Methotrexate can affect nucleotide synthesis and RNA processing, potentially impacting ELAC1. | ||||||
1-β-D-Arabinofuranosylcytosine | 147-94-4 | sc-201628 sc-201628A sc-201628B sc-201628C sc-201628D | 1 g 5 g 25 g 100 g 250 g | $147.00 $258.00 $508.00 $717.00 $1432.00 | 1 | |
A nucleoside analog used in chemotherapy that can affect RNA synthesis and processing. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A nucleoside analog that incorporates into RNA, potentially affecting RNA processing. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $40.00 $82.00 $256.00 | 127 | |
Inhibits protein synthesis, which could lead to altered RNA processing demands and indirectly affect ELAC1. | ||||||
Puromycin | 53-79-2 | sc-205821 sc-205821A | 10 mg 25 mg | $163.00 $316.00 | 436 | |
An antibiotic that inhibits protein synthesis, potentially impacting RNA processing and ELAC1 activity. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $214.00 $316.00 $418.00 | 7 | |
Similar to azacitidine, could influence RNA metabolism and indirectly affect RNA processing enzymes. |